APOE4 is Associated with Differential Regional Vulnerability to Bioenergetic Deficits in Aged APOE Mice

Tal Nuriel, Delfina Larrea, David N. Guilfoyle, Leila Pirhaji, Kathleen M. Shannon, Hirra A. Arain, Archana Ashok, Marta Pera, Qiuying Chen, Allissa Dillman, Helen Y. Figueroa, Mark Cookson, Steven S. Gross, Ernest Fraenkel, Karen Duff, Estela Área-GómezbioRxiv 2018 · DOI

Abstract

The ε4 allele of apolipoprotein E (APOE) is the dominant genetic risk factor for late-onset Alzheimer’s disease (AD). While much research has focused on the role of apoE4 in increasing Aβ aggregation and decreasing its clearance, emerging evidence suggests that APOE4 negatively impacts various other brain processes, including bioenergetics. To better understand APOE4’s role in AD pathogenesis, we performed a multi-omic analysis of APOE4 vs. APOE3 expression in the entorhinal cortex (EC) and primary visual cortex (PVC) of aged mice. These studies revealed region-specific alterations in bioenergetic pathways, including oxidative phosphorylation (OxPhos), the TCA cycle, and fatty acid metabolism. Functional analysis using the Seahorse platform revealed decreased mitochondrial respiration in the hippocampus and cortex of aged APOE4 mice, but not in the EC. Instead, the EC exhibited differential bioenergetic regulation, suggesting a unique compensatory response. Given that the EC is one of the first regions affected by AD, this differential regulation may play a critical role in AD pathogenesis among APOE4 carriers.

Introduction

The APOE4 allele is the most significant genetic risk factor for late-onset Alzheimer’s Disease (AD). For decades, the "Amyloid Cascade Hypothesis" dominated the field, focusing on how the apoE4 protein influences the accumulation of Amyloid-beta (Aβ) plaques. However, clinical imaging has long shown that APOE4 carriers exhibit decreased glucose utilization in the brain decades before the onset of clinical symptoms.

Crucially, AD does not affect the brain uniformly. The entorhinal cortex (EC) is one of the earliest sites of neurodegeneration, while the primary visual cortex (PVC) remains relatively spared until late stages. This study investigates whether APOE4 drives differential bioenergetic vulnerabilities across these regions, potentially explaining why the EC is so susceptible to early pathology.

Methodology

To isolate the effects of APOE4 from the confounding presence of overt Aβ plaques, the researchers utilized a humanized mouse model (APOE targeted replacement mice) at an advanced age (14–20 months). A systems biology approach was employed to capture a holistic view of brain metabolism:

  • Multi-omics: The team integrated transcriptomics (RNA-seq) to monitor gene expression and untargeted metabolomics to identify small-molecule metabolic signatures.
  • Seahorse XF24 Platform: This technology measured the Oxygen Consumption Rate (OCR) in isolated mitochondria, providing a direct functional assessment of mitochondrial efficiency.
  • 1H NMR Spectroscopy: This was used for in vivo measurement of metabolite concentrations in the EC of live mice.
  • Computational Integration: The PIUMet algorithm was used to map untargeted metabolomics data onto known biological networks, helping identify previously unknown metabolic shifts.

The EC Paradox: Compensation vs. Failure

The study's most striking finding was the "EC Paradox." While APOE4 typically correlates with metabolic decline, the researchers found that the EC behaves differently than other brain regions:

  1. Mitochondrial Overdrive: In the hippocampus and general cortex, APOE4 mice showed a significant reduction in Complex I-mediated respiration. However, in the EC, mitochondria actually showed an increase in the Respiratory Control Ratio (RCR), indicating higher coupling efficiency.
  2. Transcriptional Upregulation: Transcriptomic data revealed that nearly all subunits of the Electron Transport Chain (ETC) complexes I–V were upregulated specifically in the EC of APOE4 mice. This trend was absent in the resistant PVC.
  3. High-Energy Reserves: The EC of APOE4 mice maintained a higher ATP:ADP ratio and significantly elevated levels of phosphocreatine (PCr), a reserve used for rapid energy mobilization.

Metabolic Shifting and Alternative Fuels

The data suggests that the APOE4 EC is "redlining" its metabolic engines to maintain function. To fuel this high-demand state, the brain appears to shift its substrate preferences. Metabolomics showed a decrease in free fatty acids and an increase in carnitine and ketone-related pathways, suggesting a switch from glucose to fats and ketones.

Furthermore, 1H NMR revealed decreased levels of glutamate and GABA in the APOE4 EC. The authors propose that these neurotransmitters are being diverted into the TCA cycle to serve as emergency fuel, a process that may eventually compromise synaptic signaling.

The Cost of Hyper-Metabolism

While the EC’s ability to increase mitochondrial efficiency appears beneficial, it may be a double-edged sword. Running mitochondria at maximum capacity often leads to the increased production of Reactive Oxygen Species (ROS). This chronic oxidative stress can damage cellular components and may eventually lead to the very neurodegeneration seen in AD. The hyper-metabolic state observed in the aged APOE4 EC likely represents a fragile compensatory mechanism that eventually fails, leaving the region vulnerable to collapse.

Limitations and Future Directions

While these findings provide a new framework for understanding regional vulnerability, several questions remain:

  • Cellular Source: Since the study used bulk tissue, it is unclear if these shifts occur in neurons, astrocytes, or microglia.
  • Sex as a Variable: This study was conducted in male mice. Given that female APOE4 carriers are at higher risk for AD, investigating sex-specific bioenergetic responses is essential.
  • Causality: It is yet to be determined if the bioenergetic overdrive causes the neuronal hyperactivity often seen in APOE4 carriers, or if the mitochondria are simply responding to increased electrical demand.

In conclusion, the APOE4 allele does not cause a uniform metabolic deficit. Instead, it induces a region-specific hyper-metabolic state in the entorhinal cortex that may ultimately contribute to its unique vulnerability in the early stages of Alzheimer’s Disease.

Summary updated

Abstract

ABSTRACT The ε4 allele of apolipoprotein E ( APOE ) is the dominant genetic risk factor for late-onset Alzheimer’s disease (AD). However, the reason for the association between APOE4 and AD remains unclear. While much of the research has focused on the ability of the apoE4 protein to increase the aggregation and decrease the clearance of Aβ, there is also an abundance of data showing that APOE4 negatively impacts many additional processes in the brain, including bioenergetics. In order to gain a more comprehensive understanding of the APOE4 ’s role in AD pathogenesis, we performed a multi-omic analysis of APOE4 vs. APOE3 expression in the entorhinal cortex (EC) and primary visual cortex (PVC) of aged APOE mice. These studies revealed region-specific alterations in several bioenergetic pathways, including oxidative phosphorylation (OxPhos), the TCA-cycle and fatty acid metabolism. Follow-up analysis utilizing the Seahorse platform revealed decreased mitochondrial respiration in the hippocampus and cortex of aged APOE4 vs. APOE3 mice, but not in the EC of these mice. Additional studies, as well as the original multi-omic data suggest that bioernergetic pathways in the EC of aged APOE mice may be differentially regulated by APOE4 expression. Given the importance of the EC as one of the first regions to be affected by AD pathology in humans, this differential bionenergetic regulation observed in the EC vs. other brain regions of aged APOE4 mice may play an important role in the pathogenesis of AD, particularly among APOE4 carriers.
BibTeX
@misc{nuriel2018i,
  author = {Tal Nuriel and Delfina Larrea and David N. Guilfoyle and Leila Pirhaji and Kathleen M. Shannon and Hirra A. Arain and Archana Ashok and Marta Pera and Qiuying Chen and Allissa Dillman and Helen Y. Figueroa and Mark Cookson and Steven S. Gross and Ernest Fraenkel and Karen Duff and Estela Área-Gómez},
  title = {{<i>APOE4</i> is Associated with Differential Regional Vulnerability to Bioenergetic Deficits in Aged <i>APOE</i> Mice}},
  year = {2018},
  doi = {10.1101/482422},
  howpublished = {bioRxiv},
}
Figure